JY
LEGN icon

Jeff Yass’s Legend Biotech LEGN Stock Holding History

Jeff Yass’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Sell
63,900
-4,400
-6% -$119K ﹤0.01% 6672
2026
Q1 		$1.24M Sell
68,300
-90,900
-57% -$1.73M ﹤0.01% 7345
2025
Q4 		$3.46M Sell
159,200
-215,000
-57% -$6.16M ﹤0.01% 4628
2025
Q3 		$12.2M Buy
374,200
+196,400
+110% +$7.25M ﹤0.01% 2787
2025
Q2 		$6.31M Buy
177,800
+19,500
+12% +$632K ﹤0.01% 3564
2025
Q1 		$5.37M Buy
158,300
+52,500
+50% +$1.88M ﹤0.01% 3529
2024
Q4 		$3.44M Sell
105,800
-43,800
-29% -$1.81M ﹤0.01% 4204
2024
Q3 		$7.29M Buy
149,600
+2,200
+1% +$117K ﹤0.01% 3036
2024
Q2 		$6.53M Sell
147,400
-81,300
-36% -$3.75M ﹤0.01% 3038
2024
Q1 		$12.8M Buy
228,700
+106,800
+88% +$6.44M ﹤0.01% 2290
2023
Q4 		$7.33M Buy
121,900
+98,400
+419% +$6.24M ﹤0.01% 3088
2023
Q3 		$1.58M Sell
23,500
-50,100
-68% -$3.48M ﹤0.01% 5619
2023
Q2 		$5.08M Buy
73,600
+39,600
+116% +$2.59M ﹤0.01% 3507
2023
Q1 		$1.64M Sell
34,000
-31,400
-48% -$1.54M ﹤0.01% 5576
2022
Q4 		$3.26M Buy
65,400
+2,200
+3% +$107K ﹤0.01% 3878
2022
Q3 		$2.58M Sell
63,200
-40,900
-39% -$1.92M ﹤0.01% 4391
2022
Q2 		$5.73M Sell
104,100
-21,000
-17% -$887K ﹤0.01% 2968
2022
Q1 		$4.55M Buy
125,100
+75,300
+151% +$2.98M ﹤0.01% 3793
2021
Q4 		$2.32M Buy
49,800
+29,600
+147% +$1.5M ﹤0.01% 5161
2021
Q3 		$1.02M Buy
20,200
+4,400
+28% +$183K ﹤0.01% 7509
2021
Q2 		$649K Buy
15,800
+7,400
+88% +$252K ﹤0.01% 8926
2021
Q1 		$244K Buy
+8,400
New +$229K ﹤0.01% 11041

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Jeff Yass's LEGN Position: Q2 2026 in Review

Jeff Yass reduced its Legend Biotech (LEGN) stake by 81% in Q2 2026, selling an estimated $3.97M and leaving 35,348 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #8143.

Jeff Yass first reported a position in LEGN in Q1 2021 and has held it in 17 quarters since. The position peaked at $8.74M in Q2 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Jeff Yass held 35,348 shares of Legend Biotech worth $1.02M as of Q2 2026.
  • Jeff Yass sold 147,016 Legend Biotech shares in Q2 2026, an estimated $3.97M.
  • Legend Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8143 holding.
  • Jeff Yass first reported a position in Legend Biotech in Q1 2021 and has held it in 17 quarters since.
  • Jeff Yass's Legend Biotech position peaked at $8.74M in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.